Elucid Bioimaging
Latest round
- Series D
Last raised
- Sep 2026
Total raised
- $90M
Investors
- 11
About Elucid Bioimaging
Based in Massachusetts, US, and founded in 2013, Elucid Bioimaging Inc. is a medical technology company that develops AI-powered cardiovascular imaging software. Marc Manley serves as Founder and Executive Chairman, while Kelly Huang serves as CEO. Elucid uses machine learning and historical data to diagnose and treat cardiovascular disease accurately. The company’s product is ElucidVivo with PlaqueIQTM Technology includes image analysis software that employs CT angiography and patented computer algorithms based on histological data which is to find the actual position of arterial plaque to create personalized patient care. The software works with all CTA Scanners using standard acquisition protocols and sensitive patient data is protected. The software uses an electronic medical recorder (EMR) and picture archiving and communication system (PACS) for timely clinical decision-making. Elucid also provides a software named ElucidVivo™ Clinical Research for clinical research and studies.
Who invested in Elucid Bioimaging
11 investors across 3 rounds
See all investors in Elucid Bioimaging
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elucid Bioimaging
Who invested in Elucid Bioimaging?
Elucid Bioimaging has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elucid Bioimaging raised?
Elucid Bioimaging has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Elucid Bioimaging last raise money?
Elucid Bioimaging's most recent round on record is a Series D, in Sep 2026.
What does Elucid Bioimaging do?
Based in Massachusetts, US, and founded in 2013, Elucid Bioimaging Inc.
Where is Elucid Bioimaging headquartered?
Elucid Bioimaging is headquartered in Boston, US.
Which VCs invest in companies like Elucid Bioimaging?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Elucid Bioimaging's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Elucid Bioimaging? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.